<DOC>
	<DOCNO>NCT01986504</DOCNO>
	<brief_summary>The Transplant Infectious Diseases Prospective Cohort Study facilitate prospective identification collection data infectious disease complication order determine epidemiology , risk factor , outcomes patient receive solid organ stem cell plastic surgery transplant Johns Hopkins transplant center . It essential care treatment population employ mechanism investigator centralize datasets , use standardized definition infectious complication . This protocol outline procedure utilized order prospectively follow diagnosis treatment infectious complication transplant patient .</brief_summary>
	<brief_title>The Johns Hopkins Transplant Infectious Diseases Prospective Cohort Study</brief_title>
	<detailed_description>Patients approach transplant screen visit , possible , hospital stay ( transplant ) order introduce study obtain informed consent participation . A letter transplant physician introduce study . Data collection begin immediately upon consent continue five year . The informed consent form specifically request permission contact subject future verify information subject lose follow Transplant service . The Day transplant consider day 0 enrollment observational study . Data collect clinical template form complete study team member , infectious complication become apparent either outpatient ID clinic inpatient service . A member research team complete data collection registry , maintain REDCap platform . In addition , patient electronic record review every 3 month identify record infectious complication , treatment administer , outcome . During interval , subject contact phone review outcome . Creation registry relies use standardized definition define infection . An electronic database construct REDCap system , document subject demographic , transplant variable , infection variable , treatment administer , overall outcome , interim time period .</detailed_description>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<criteria>Hematopoietic stem cell ( bone marrow ) solid organ transplant patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Infection</keyword>
	<keyword>Cohort</keyword>
	<keyword>Prospective</keyword>
	<keyword>Epidemiology</keyword>
	<keyword>Outcome</keyword>
</DOC>